Healthcare -
Biotechnology - NYSE - US
$ 10.52
-3.4 %
$ 1.11 B
Market Cap
-3.35
P/E
Price Target
Average
205.37%
Revenue Forecast
Estimate
76.95%
EBIT
Estimate
--13.72%
Net Income
Estimate
34.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Arcus Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for RCUS of $32.1 , with forecasts ranging from
a
low of
$20 to a high of $46 .
RCUS Lowest Price Target
Wall Street Target
20 USD
90.11%
RCUS Average Price Target
Wall Street Target
32.1 USD
205.37%
RCUS Highest Price Target
Wall Street Target
46 USD
337.26%
REVENUE FORECAST
Revenue Forecast Chart RCUS
EBIT FORECAST
EBIT Forecast Chart RCUS
NET INCOME FORECAST
Net Income Chart RCUS